These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24065412)

  • 1. [Psoriatic arthritis and general recommendations for targeted therapy of spondyloarthritis].
    Märker-Hermann E
    Dtsch Med Wochenschr; 2013 Oct; 138(40):2037-40. PubMed ID: 24065412
    [No Abstract]   [Full Text] [Related]  

  • 2. The Bench-to-Bedside Story of IL-17 and the Therapeutic Efficacy of its Targeting in Spondyloarthritis.
    Smith JA
    Curr Rheumatol Rep; 2016 Jun; 18(6):33. PubMed ID: 27105640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spondyloarthritis: from unifying concepts to improved treatment.
    Paramarta JE; Baeten D
    Rheumatology (Oxford); 2014 Sep; 53(9):1547-59. PubMed ID: 24369419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Spondyloarthritis including psoriatic arthritis].
    Rudwaleit M; Märker-Hermann E
    Dtsch Med Wochenschr; 2011 Oct; 136(40):2033-6. PubMed ID: 21960334
    [No Abstract]   [Full Text] [Related]  

  • 5. Infection relapse in spondyloarthritis treated with biological drugs: a single-centre study.
    Modesti V; Ramonda R; Ortolan A; Lorenzin M; Lo Nigro A; Frallonardo P; Oliviero F; Campana C; Punzi L
    Scand J Rheumatol; 2012; 41(6):490-1. PubMed ID: 22985209
    [No Abstract]   [Full Text] [Related]  

  • 6. Peripheral spondyloarthritis: Concept, diagnosis and treatment.
    Molto A; Sieper J
    Best Pract Res Clin Rheumatol; 2018 Jun; 32(3):357-368. PubMed ID: 31171308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy for spondyloarthritis: the role of extra-articular manifestations (eye, skin).
    Carron P; Van Praet L; Jacques P; Elewaut D; Van den Bosch F
    Rheum Dis Clin North Am; 2012 Aug; 38(3):583-600. PubMed ID: 23083757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation, new bone formation and treatment options in axial spondyloarthritis.
    Sieper J; Poddubnyy D
    Ann Rheum Dis; 2014 Aug; 73(8):1439-41. PubMed ID: 24812284
    [No Abstract]   [Full Text] [Related]  

  • 9. Early spondyloarthritis.
    Poddubnyy D; Rudwaleit M
    Rheum Dis Clin North Am; 2012 May; 38(2):387-403. PubMed ID: 22819091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis.
    Olivieri I; D'Angelo S; Palazzi C; Leccese P; Nigro A; Padula A
    Reumatismo; 2013 Mar; 65(1):1-3. PubMed ID: 23550255
    [No Abstract]   [Full Text] [Related]  

  • 11. Peripheral spondyloarthritis: a neglected entity-state of the art.
    Carron P; De Craemer AS; Van den Bosch F
    RMD Open; 2020 May; 6(1):. PubMed ID: 32385142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on anti-tumor necrosis factor therapy in the spondyloarthropathies including psoriatic arthritis.
    Kavanaugh A; Tutuncu Z; Catalan-Sanchez T
    Curr Opin Rheumatol; 2006 Jul; 18(4):347-53. PubMed ID: 16763453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel targeted therapies: the future of rheumatoid arthritis? Mavrilumab and tabalumab as examples.
    Combe B; van Vollenhoven R
    Ann Rheum Dis; 2013 Sep; 72(9):1433-5. PubMed ID: 23625979
    [No Abstract]   [Full Text] [Related]  

  • 14. Unanswered questions in the management of axial spondyloarthritis: an opinion piece.
    Baraliakos X; Deodhar A
    Clin Rheumatol; 2014; 33(10):1359-65. PubMed ID: 24941929
    [No Abstract]   [Full Text] [Related]  

  • 15. The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis.
    Zochling J; Brandt J; Braun J
    Rheumatology (Oxford); 2005 Dec; 44(12):1483-91. PubMed ID: 16091395
    [No Abstract]   [Full Text] [Related]  

  • 16. [Protocol for inducing infliximab tolerance in a patient with psoriatic spondylarthritis].
    Gallardo R; Fobelo MJ; Pastor C; Orta-Cuevas JC
    Farm Hosp; 2010; 34(2):94-6. PubMed ID: 20304368
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents.
    Gao X; Wendling D; Botteman MF; Carter JA; Rao S; Cifaldi M
    J Med Econ; 2012; 15(6):1054-63. PubMed ID: 22563743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis.
    van der Heijde D; Sieper J; Maksymowych WP; Dougados M; Burgos-Vargas R; Landewé R; Rudwaleit M; Braun J;
    Ann Rheum Dis; 2011 Jun; 70(6):905-8. PubMed ID: 21540200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis.
    Maksymowych WP; Inman RD; Gladman D; Thomson G; Stone M; Karsh J; Russell AS;
    J Rheumatol; 2003 Jun; 30(6):1356-63. PubMed ID: 12784417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spondyloarthritis: Is methotrexate effective in psoriatic arthritis?
    Mease PJ
    Nat Rev Rheumatol; 2012 May; 8(5):251-2. PubMed ID: 22549279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.